Search research articles
Contact Us
Filters
Showing results (251-260 of 501) with videos related to
Page
of 51
Sort By:
European Journal of Radiology
|
March 15, 2016
CT imaging of bone and bone marrow infiltration in malignant melanoma--Challenges and limitations for clinical staging in comparison to 18FDG-PET/CT
Georg Bier, Vera Hoffmann, Christopher Kloth, et al.
Melanoma Research
|
September 11, 2008
Adjuvant treatment with vindesine in comparison to observation alone in patients with metastasized melanoma after complete metastasectomy: a randomized multicenter trial of the German Dermatologic Cooperative Oncology Group
Thomas K Eigentler, Peter Radny, Axel Hauschild, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
October 22, 2021
30 years German Dermatologic Cooperative Oncology Group (DeCOG)
Claus Garbe, Dirk Schadendorf, Wolfgang Tilgen, et al.
Annals of Surgical Oncology
|
February 26, 2015
Sentinel Lymph Node Dissection in Head and Neck Melanoma has Prognostic Impact on Disease-Free and Overall Survival
Ulrike Leiter, Thomas K Eigentler, Hans-Martin Häfner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 10, 2023
Adjuvant therapy for stage II melanoma: the need for further studies
Rebecca Lee, Mario Mandala, Georgina V Long, et al.
Melanoma Research
|
November 15, 2011
Prospective evaluation of supportive care with or without CVD chemotherapy as a second-line treatment in advanced melanoma by patient's choice: a multicentre Dermatologic Cooperative Oncology Group trial
Maja A Hofmann, Axel Hauschild, Peter Mohr, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 1, 2022
Diagnostic and prognostic classification of atypical spitzoid tumours based on histology and genomic aberrations: A prospective cohort study with long-term follow-up
Maximilian Gassenmaier, Narges Soltanpour, Laura Held, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
April 23, 2021
PET/CT in malignant melanoma: a two-tiered healthcare system? Updated healthcare situation regarding initial staging of malignant melanoma with PET/CT
Antonia Matiszick, Charlyn Völker, Claus Garbe, et al.
Cancer
|
April 8, 2011
Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma
Thomas K Eigentler, Adina Figl, Dietmar Krex, et al.
Cancer Immunology, Immunotherapy : CII
|
October 9, 2017
Safety of shortened infusion times for combined ipilimumab and nivolumab
Maximilian Gassenmaier, Hans-Peter Lipp, Alexander Scheu, et al.
Page
of 51
Search research articles
Search
Showing results (251-260 of 501) with videos related to
Sort By:
Page
of 51
European Journal of Radiology
|
March 15, 2016
CT imaging of bone and bone marrow infiltration in malignant melanoma--Challenges and limitations for clinical staging in comparison to 18FDG-PET/CT
Georg Bier, Vera Hoffmann, Christopher Kloth, et al.
Melanoma Research
|
September 11, 2008
Adjuvant treatment with vindesine in comparison to observation alone in patients with metastasized melanoma after complete metastasectomy: a randomized multicenter trial of the German Dermatologic Cooperative Oncology Group
Thomas K Eigentler, Peter Radny, Axel Hauschild, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
October 22, 2021
30 years German Dermatologic Cooperative Oncology Group (DeCOG)
Claus Garbe, Dirk Schadendorf, Wolfgang Tilgen, et al.
Annals of Surgical Oncology
|
February 26, 2015
Sentinel Lymph Node Dissection in Head and Neck Melanoma has Prognostic Impact on Disease-Free and Overall Survival
Ulrike Leiter, Thomas K Eigentler, Hans-Martin Häfner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 10, 2023
Adjuvant therapy for stage II melanoma: the need for further studies
Rebecca Lee, Mario Mandala, Georgina V Long, et al.
Melanoma Research
|
November 15, 2011
Prospective evaluation of supportive care with or without CVD chemotherapy as a second-line treatment in advanced melanoma by patient's choice: a multicentre Dermatologic Cooperative Oncology Group trial
Maja A Hofmann, Axel Hauschild, Peter Mohr, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 1, 2022
Diagnostic and prognostic classification of atypical spitzoid tumours based on histology and genomic aberrations: A prospective cohort study with long-term follow-up
Maximilian Gassenmaier, Narges Soltanpour, Laura Held, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
April 23, 2021
PET/CT in malignant melanoma: a two-tiered healthcare system? Updated healthcare situation regarding initial staging of malignant melanoma with PET/CT
Antonia Matiszick, Charlyn Völker, Claus Garbe, et al.
Cancer
|
April 8, 2011
Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma
Thomas K Eigentler, Adina Figl, Dietmar Krex, et al.
Cancer Immunology, Immunotherapy : CII
|
October 9, 2017
Safety of shortened infusion times for combined ipilimumab and nivolumab
Maximilian Gassenmaier, Hans-Peter Lipp, Alexander Scheu, et al.
Page
of 51